Implantica AG Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 5/5/2026)
| Balance Sheet | Total Assets | 930,041,015.88 | ROE | 98.98 % |
| Balance Sheet | Total Equity | 84,732,010.00 | ROA | -23.36 % |
| Cashflow | Capital Expenditures | -65,200.00 | P/FCF | -266.09 |
| Cashflow | Free Cash Flow | -16,261,265.00 | – | – |
| Cashflow | Operating Cash Flow | -16,196,065.00 | P/CF | -267.16 |
| Income | Earnings per Share (diluted) | -0.29 | Div. Yield | – |
| Income | Net Income | -19,993,959.00 | P/E | -214.48 |
| Income | Shares Outstanding | 69,565,400.00 | P/B | 51.07 |
| Income | Total Revenue | 22,945,087.40 | P/S | 2,048.88 |
Ratios calculated on: 10/14/2026
Company Description
Implantica AG researches, develops, commercializes, and sells medical implants in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, it develops UriControl, a remote controlled artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for the treatment of aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.implantica.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more